GPT Healthcare Limited has launched the Second 100 Days Campaign 'Saksham Niveshak' to facilitate shareholders in claiming unpaid or unclaimed dividends and completing KYC formalities. The campaign, running from April 1, 2026, to July 9, 2026, follows a circular dated March 27, 2026, issued by the Investor Education and Protection Fund Authority (IEPFA), Ministry of Corporate Affairs (MCA). The initiative aims to prevent the transfer of shares and unpaid dividends to the IEPF by ensuring shareholders update their records and claim pending amounts.

The company dispatched letters on June 8, 2026, to shareholders whose dividends remain unpaid or unclaimed, urging them to take necessary actions. Shareholders are required to update details such as PAN, nomination information, contact details, bank account particulars, and specimen signatures with the company's Registrar and Transfer Agent (RTA), MUFG Intime India Private Limited, or their respective depositories.

Key Actions and Submission Process

Shareholders holding shares in physical form must submit specific forms to the RTA to update their details or claim dividends. The required forms include ISR-1 for KYC updation, ISR-2 for signature verification, ISR-3 for opting out of nomination, SH-13 for adding a nominee, and SH-14 for cancellation or variation of nomination.

Documents can be submitted via post to MUFG Intime India Private Limited, Unit: GPT Healthcare Limited, Rasoi Court, 5th floor 20, Sir R N Mukherjee Road, Kolkata – 700001, or via email from a registered email ID. Shareholders can also upload requests through the MUFG portal or track them via the SWAYAM portal.

Shareholders holding shares in dematerialized mode must first update their KYC details with their Depository Participants before contacting the RTA to claim unpaid dividends. The company has made the necessary forms available on its website and the RTA's website. This initiative is part of the company's investor awareness efforts to ensure compliance with regulatory directives and safeguard shareholder investments.

GPT Healthcare Limited has scheduled a meeting with analysts and institutional investors on June 11, 2026. The session, part of the InsightX 2026 Choice Virtual Conference, will be conducted virtually at 3:00 PM IST. The company stated that no unpublished price sensitive information will be shared during the interaction.

The meeting is being held pursuant to Regulation 30(6) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The Investor Presentation for Q4FY26, which ended March 2026, is already available in the public domain on the company's website and the stock exchanges' websites. This existing presentation will be utilized during the meeting.

The following table outlines the schedule for the meeting:

GPT Healthcare noted that changes to the schedule may occur due to exigencies on the part of investors, analysts, or the company. Ankur Sharma, Company Secretary and Compliance Officer, signed the intimation regarding the schedule on June 5, 2026.